Dinutuximab Active Not Recruiting Phase 2 Trials for Metastatic Bone Sarcomas / Recurrent Osteosarcoma / Metastatic Malignant Neoplasm in the Lung Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02484443Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma